BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2009
View Archived Issues
Omeprazole immediate-release exhibits favorable pharmacokinetics in GERD patients with gastroparesis
Read More
Safety, pharmacokinetic results with ZYH-1 in healthy subjects reported
Read More
GPR119 agonist MBX-2982 shows potential in treating diabetes
Read More
Promising first-in-human results for CAM-3001 in rheumatoid arthritis
Read More
Update on phase III results for eplivanserin in insomnia
Read More
Clinical studies of ENB-0040 in hypophosphatasia patients reported
Read More
11beta-HSD1 inhibition may benefit cognition
Read More
Novel ORL-1 antagonist with a favorable preclinical profile enters clinical trials as an analgesic
Read More
ActoGeniX receives FDA approval to initiate phase Ib clinical trials of AG-013 in cancer
Read More
FDA accepts for standard review IntelGenx's NDA for antidepressant CPI-300
Read More
Javelin completes safety study of Dyloject in the U.S. in acute postoperative pain
Read More
PharmaSwiss submits NDA in Israel for BioSante's Elestrin
Read More
Nippon Boehringer Ingelheim and Astellas launch Micombi for hypertension in Japan
Read More
GSK and Chroma to develop macrophage-targeted drugs using Chroma's ESM technology
Read More
Takeda completes tender offer for all outstanding shares of IDM Pharma common stock
Read More
Cytopia files IND with FDA for JAK2 inhibitor CYT-387
Read More
National Jewish Health reports results from preclinical animal testing of Ceragenix's CSA-13
Read More
Biovista presents efficacy results in a preclinical trial of BVA-601
Read More
Compugen reports therapeutic effects of novel peptide in animal model of IBS
Read More
Kyowa Hakko Kirin initiates phase II study for KW-0761 in T-cell lymphoma
Read More
Resolvyx initiates phase I RX-10001 trial for asthma and inflammatory diseases
Read More
Restanza shows 100% survival in confirmatory nonhuman primate anthrax study
Read More
Silence Therapeutics doses first patient in ATU-027 trial for solid tumors
Read More
Novel HIV-1 Nef protein ligands claimed by INSERM and CNRS for the treatment of AIDS
Read More
deCODE describes PDE4 inhibitors in development for the treatment of stroke
Read More